These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 31565740)
1. Characterization of the developmental landscape of murine RORγt+ iNKT cells. Klibi J; Li S; Amable L; Joseph C; Brunet S; Delord M; Parietti V; Jaubert J; Marie J; Karray S; Eberl G; Lucas B; Toubert A; Benlagha K Int Immunol; 2020 Feb; 32(2):105-116. PubMed ID: 31565740 [TBL] [Abstract][Full Text] [Related]
2. Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Michel ML; Mendes-da-Cruz D; Keller AC; Lochner M; Schneider E; Dy M; Eberl G; Leite-de-Moraes MC Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19845-50. PubMed ID: 19057011 [TBL] [Abstract][Full Text] [Related]
3. Development and function of murine RORγt+ iNKT cells are under TGF-β signaling control. Havenar-Daughton C; Li S; Benlagha K; Marie JC Blood; 2012 Apr; 119(15):3486-94. PubMed ID: 22371886 [TBL] [Abstract][Full Text] [Related]
4. CD138 expression is a molecular signature but not a developmental requirement for RORγt+ NKT17 cells. Luo S; Kwon J; Crossman A; Park PW; Park JH JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34549726 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal Invariant NKT (iNKT) Cell Mice Reveal a Role for Both Tissue of Origin and the TCR in Development of iNKT Functional Subsets. Clancy-Thompson E; Chen GZ; Tyler PM; Servos MM; Barisa M; Brennan PJ; Ploegh HL; Dougan SK J Immunol; 2017 Jul; 199(1):159-171. PubMed ID: 28576977 [TBL] [Abstract][Full Text] [Related]
6. IgG from atopic dermatitis patients induces non-atopic infant thymic invariant natural killer T (iNKT) cells to produce IL-4, IL-17, and IL-10. Santos LS; Sgnotto FDR; Sousa TR; Orfali RL; Aoki V; Duarte AJDS; Victor JR Int J Dermatol; 2020 Mar; 59(3):359-364. PubMed ID: 31631342 [TBL] [Abstract][Full Text] [Related]
7. The differentiation of ROR-γt expressing iNKT17 cells is orchestrated by Runx1. Thapa P; Manso B; Chung JY; Romera Arocha S; Xue HH; Angelo DBS; Shapiro VS Sci Rep; 2017 Aug; 7(1):7018. PubMed ID: 28765611 [TBL] [Abstract][Full Text] [Related]
8. RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients. Venken K; Jacques P; Mortier C; Labadia ME; Decruy T; Coudenys J; Hoyt K; Wayne AL; Hughes R; Turner M; Van Gassen S; Martens L; Smith D; Harcken C; Wahle J; Wang CT; Verheugen E; Schryvers N; Varkas G; Cypers H; Wittoek R; Piette Y; Gyselbrecht L; Van Calenbergh S; Van den Bosch F; Saeys Y; Nabozny G; Elewaut D Nat Commun; 2019 Jan; 10(1):9. PubMed ID: 30602780 [TBL] [Abstract][Full Text] [Related]
9. SLAM-associated protein favors the development of iNKT2 over iNKT17 cells. Michel ML; Lenoir C; Massot B; Diem S; Pasquier B; Sawa S; Rignault-Bricard R; Lehuen A; Eberl G; Veillette A; Leite-de-Moraes M; Latour S Eur J Immunol; 2016 Sep; 46(9):2162-74. PubMed ID: 27338553 [TBL] [Abstract][Full Text] [Related]
10. Murine CD8 Oh S; Lee H; Shin JH; Hong C; Park SH Immunol Invest; 2018 Jan; 47(1):89-100. PubMed ID: 29099628 [TBL] [Abstract][Full Text] [Related]
11. iNKT17 cells play a pathogenic role in ethinylestradiol-induced cholestatic hepatotoxicity. Kong W; Li X; Zou M; Zhang Y; Cai H; Zhang L; Wang X Arch Toxicol; 2023 Feb; 97(2):561-580. PubMed ID: 36329302 [TBL] [Abstract][Full Text] [Related]
12. β-Catenin is required for the differentiation of iNKT2 and iNKT17 cells that augment IL-25-dependent lung inflammation. Berga-Bolaños R; Sharma A; Steinke FC; Pyaram K; Kim YH; Sultana DA; Fang JX; Chang CH; Xue HH; Heller NM; Sen JM BMC Immunol; 2015 Oct; 16():62. PubMed ID: 26482437 [TBL] [Abstract][Full Text] [Related]
13. NKAP Regulates Invariant NKT Cell Proliferation and Differentiation into ROR-γt-Expressing NKT17 Cells. Thapa P; Chen MW; McWilliams DC; Belmonte P; Constans M; Sant'Angelo DB; Shapiro VS J Immunol; 2016 Jun; 196(12):4987-98. PubMed ID: 27183586 [TBL] [Abstract][Full Text] [Related]
14. A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations. Imura C; Ueyama A; Sasaki Y; Shimizu M; Furue Y; Tai N; Tsujii K; Katayama K; Okuno T; Shichijo M; Yasui K; Yamamoto M J Dermatol Sci; 2019 Mar; 93(3):176-185. PubMed ID: 30905492 [TBL] [Abstract][Full Text] [Related]
15. Concomitant suppression of T Na H; Lim H; Choi G; Kim BK; Kim SH; Chang YS; Nurieva R; Dong C; Chang SH; Chung Y J Allergy Clin Immunol; 2018 Jun; 141(6):2061-2073.e5. PubMed ID: 28943467 [TBL] [Abstract][Full Text] [Related]
16. RORγT is overexpressed in iNKT and γδ T cells during relapse in relapsing-remitting multiple sclerosis. Zarobkiewicz MK; Kowalska W; Halczuk P; Woś J; Jodłowska-Jędrych B; Rejdak K; Roliński J; Bojarska-Junak AA J Neuroimmunol; 2019 Dec; 337():577046. PubMed ID: 31505409 [TBL] [Abstract][Full Text] [Related]
17. iNKT subsets differ in their developmental and functional requirements on Foxo1. Zhang H; Zhang Y; Pan J; Wu Q; Huang Y; Bai S; Tian C; Zhu M; Lian Z; Li F; Tian Z; Bai L Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34772808 [TBL] [Abstract][Full Text] [Related]
19. Pbrm1 intrinsically controls the development and effector differentiation of iNKT cells. Wang X; Lei L; Su Y; Liu J; Yuan N; Gao Y; Yang X; Sun C; Ning B; Zhang B J Cell Mol Med; 2022 Aug; 26(15):4268-4276. PubMed ID: 35770325 [TBL] [Abstract][Full Text] [Related]
20. Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival. Uddin MN; Sultana DA; Lorentsen KJ; Cho JJ; Kirst ME; Brantly ML; Califano D; Sant'Angelo DB; Avram D Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7608-13. PubMed ID: 27330109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]